Comparison of pantoprazole 20 mg twice daily with 40 mg once daily on intragastric pH in healthy volunteers.

被引：3
|
作者：
Mönnikes, H
Weber, S
Tebbe, J
Lühmann, R
Fischer, R
Arnold, R
Koop, H
机构：
[1] Univ Marburg, Sch Med, Marburg, Germany
[2] Hosp Buch, Berlin, Germany
[3] Byk Gulden, Constance, Germany
来源：
GASTROENTEROLOGY | 1998年 / 114卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(98)80942-6
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
G0950
引用
收藏
页码：A232 / A232
页数：1
相关论文
共 50 条
  • [1] Comparison of pantoprazole (40 mg sid) versus omeprazole (40 mg sid) on intragastric pH and serum gastrin in healthy volunteers.
    Brunner, G
    DanzNeeff, H
    Athmann, C
    Samayoa, N
    [J]. GASTROENTEROLOGY, 1997, 112 (04) : A78 - A78
  • [2] Comparison of the 24 hours intragastric pH profiles after 30 mg lansoprazole and 40 mg pantoprazole in healthy volunteers.
    Florent, C
    Forestier, S
    Akrour, O
    [J]. GASTROENTEROLOGY, 1996, 110 (04) : A109 - A109
  • [3] Intragastric acidity during treatment with esomeprazole 40 mg twice daily or pantoprazole 40 mg twice daily - a randomized, two-way crossover study
    Miehlke, S
    Madisch, A
    Kirsch, C
    Lindner, F
    Kuhlisch, E
    Laass, M
    Knoth, H
    Morgner, A
    Labenz, J
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (08) : 963 - 967
  • [4] Dose-dependent control of intragastric pH by pantoprazole, 10, 20 or 40 mg, in healthy volunteers
    Tutuian, R
    Katz, PO
    Bochenek, W
    Castell, DO
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2002, 16 (04) : 829 - 836
  • [5] Randomised trial of acid inhibition by vonoprazan 10/20 mg once daily vs rabeprazole 10/20 mg twice daily in healthy Japanese volunteers (SAMURAI pH study)
    Takeuchi, Toshihisa
    Furuta, Takahisa
    Fujiwara, Yasuhiro
    Sugimoto, Mitsushige
    Kasugai, Kunio
    Kusano, Motoyasu
    Okada, Hiroyuki
    Suzuki, Takahiro
    Higuchi, Tomohiro
    Kagami, Takuma
    Uotani, Takahiro
    Yamade, Mihoko
    Sawada, Akinari
    Tanaka, Fumio
    Harada, Satoshi
    Ota, Kazuhiro
    Kojima, Yuichi
    Murata, Masaki
    Tamura, Yasuhiro
    Funaki, Yasushi
    Kawamura, Osamu
    Okamoto, Yuki
    Fujimoto, Kazuma
    Higuchi, Kazuhide
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2020, 51 (05) : 534 - 543
  • [6] Acid-suppressive efficacy of a reduced dosage of rabeprazole: Comparison of 10 mg twice daily rabeprazole with 20 mg twice daily rabeprazole, 30 mg twice daily lansoprazole, and 20 mg twice daily omeprazole by 24-hr intragastric pH-metry
    Shimatani, T
    Inoue, M
    Kuroiwa, T
    Xu, J
    Tazuma, S
    Horikawa, Y
    Nakamura, M
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (07) : 1202 - 1206
  • [7] Acid-Suppressive Efficacy of a Reduced Dosage of Rabeprazole: Comparison of 10 Mg Twice Daily Rabeprazole with 20 Mg Twice Daily Rabeprazole, 30 Mg Twice Daily Lansoprazole, and 20 Mg Twice Daily Omeprazole by 24-Hr Intragastric pH-metry
    Tomohiko Shimatani
    Masaki Inoue
    Tomoko Kuroiwa
    Jing Xu
    Susumu Tazuma
    Yoko Horikawa
    Masuo Nakamura
    [J]. Digestive Diseases and Sciences, 2005, 50 : 1202 - 1206
  • [8] Rabeprazole 20 mg compared with esomeprazole 40 mg in the control of intragastric pH in healthy volunteers
    Baisley, K
    Warrington, S
    Tejura, B
    Morocutti, A
    Miller, N
    [J]. GUT, 2002, 50 : A63 - A63
  • [9] Rabeprazole 20 mg compared with esomeprazole 40 mg in the control of intragastric pH in healthy volunteers
    Baisley, K
    Warrington, S
    Tejura, B
    Morocutti, A
    Miller, N
    [J]. GASTROENTEROLOGY, 2002, 122 (04) : A199 - A199
  • [10] Rabeprazole, 20 mg once daily or 10 mg twice daily, is equivalent to omeprazole, 20 mg once daily, in the healing of erosive gastrooesophageal reflux disease
    Delchier, JC
    Cohen, G
    Humphries, TJ
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2000, 35 (12) : 1245 - 1250
12345